Does Captive Insurance Improve Firm Value? Evidence from S&P 500 Companies
Asia-Pacific Journal of Risk and Insurance · 18.12.2019 · 14 (1)
DOI: 10.1515/apjri-2018-0009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Risk and Insurance, online erschienen am 22.03.2019. Verfasst von Mu-Sheng Chang und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
This study investigates whether the use of captive insurers affects firm value for companies included in the S&P 500. Companies may use a captive insurance subsidiary to retain their risks for a lower cost than they would pay in premiums to a third-party insurer. Although captives are present in more than one-third of all firm-years between 2000 and 2016, this study fails to find evidence that owning a captive increases firm value effectively. Additional analysis reveals that firms that are larger, are listed on the New York Stock Exchange (NYSE), and have smaller proportions of capital expenditures and cash reserves tend to use captives. Overall, the results are inconsistent with previous research indicating that the market reacts positively to captive formation around the formation date. This suggests that incentives other than shareholder value maximization may have encouraged the use of captives during the sample period.
Zitieren
APA
Chang, M., & Chen, J. (2019). Does Captive Insurance Improve Firm Value? Evidence from S&P 500 Companies. Asia-Pacific Journal of Risk and Insurance, 14(1). https://doi.org/10.1515/apjri-2018-0009
Vancouver
Chang M, Chen J. Does Captive Insurance Improve Firm Value? Evidence from S&P 500 Companies. Asia-Pacific Journal of Risk and Insurance. 2019;14(1). doi:10.1515/apjri-2018-0009
BibTeX
@article{Chang2019,
author = {Chang, Mu-Sheng and Chen, Jiun-Lin},
title = {Does Captive Insurance Improve Firm Value? Evidence from S&P 500 Companies},
journal = {Asia-Pacific Journal of Risk and Insurance},
year = {2019},
volume = {14},
number = {1},
doi = {10.1515/apjri-2018-0009}
}
EUVIMED